| 1-chloro-2,4-dinitrobenzene | affects metabolic processing | ISO | RGD:1349768 | 6480464 | GSTM3 protein affects the metabolism of Dinitrochlorobenzene | CTD | PMID:9545290 |
| 1-chloro-2,4-dinitrobenzene | affects metabolic processing | EXP | | 6480464 | GSTM3 protein affects the metabolism of Dinitrochlorobenzene | CTD | PMID:3169012 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of GSTM3 protein | CTD | PMID:9794801 |
| 1-chloro-2,4-dinitrobenzene | increases metabolic processing | ISO | RGD:1349768 | 6480464 | GSTM3 protein polymorphism results in increased metabolism of Dinitrochlorobenzene | CTD | PMID:15247628 |
| 1-chloro-2,4-dinitrobenzene | decreases metabolic processing | ISO | RGD:1349768 | 6480464 | GSTM3 protein polymorphism results in decreased metabolism of Dinitrochlorobenzene | CTD | PMID:15247628 |
| 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1620117 | 6480464 | Ethinyl Estradiol affects the expression of GSTM3 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:15834898 more ... |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:17557909 more ... |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:15834898 more ... |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:15576828 more ... |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1620117 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GSTM3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1620117 | 6480464 | Ethinyl Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | increases expression | ISO | RGD:1349768 | 6480464 | Estradiol results in increased expression of GSTM3 mRNA | CTD | PMID:11331657 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| 17beta-estradiol | decreases expression | ISO | RGD:1620117 | 6480464 | Estradiol results in decreased expression of GSTM3 mRNA | CTD | PMID:14664709 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1349768 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GSTM3 mRNA | CTD | PMID:16039398 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1620117 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA | CTD | PMID:19474220 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1620117 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1620117 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA | CTD | PMID:19474220 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1620117 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA | CTD | PMID:18172886 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1620117 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GSTM3 mRNA | CTD | PMID:19465110 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1620117 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of GSTM3 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1620117 | 6480464 | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTM3 mRNA] | CTD | PMID:19474220 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1620117 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of GSTM3 mRNA | CTD | PMID:16214954 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of GSTM3 mRNA | CTD | PMID:21346803 |
| 2,6-dichloroindophenol | multiple interactions | ISO | RGD:1349768 | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GSTM3 mRNA | CTD | PMID:21034357 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of GSTM3 mRNA | CTD | PMID:21346803 |
| 2-nonenal | increases metabolic processing | ISO | RGD:1349768 | 6480464 | GSTM3 protein polymorphism results in increased metabolism of 2-nonenal | CTD | PMID:15247628 |
| 2-nonenal | decreases metabolic processing | ISO | RGD:1349768 | 6480464 | GSTM3 protein polymorphism results in decreased metabolism of 2-nonenal | CTD | PMID:15247628 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1349768 | 6480464 | [decitabine affects the methylation of GSTM3 promoter] which affects the expression of GSTM3 mRNA | CTD | PMID:18664505 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1349768 | 6480464 | [decitabine affects the methylation of GSTM3 promoter] which affects the expression of GSTM3 mRNA | CTD | PMID:18664505 PMID:18664505 |
| aflatoxin B1 | decreases expression | ISO | RGD:1620117 | 6480464 | Aflatoxin B1 results in decreased expression of GSTM3 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1349768 | 6480464 | Tretinoin results in increased expression of GSTM3 mRNA | CTD | PMID:21934132 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GSTM3 mRNA | CTD | PMID:16483693 |
| andrographolide | multiple interactions | ISO | RGD:1620117 | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM3 mRNA | CTD | PMID:19737545 |
| andrographolide | increases expression | ISO | RGD:1620117 | 6480464 | andrographolide results in increased expression of GSTM3 mRNA | CTD | PMID:19737545 |
| aristolochic acid | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of GSTM3 mRNA | CTD | PMID:17483316 |
| arsenic atom | increases expression | ISO | RGD:1349768 | 6480464 | Arsenic results in increased expression of GSTM3 mRNA | CTD | PMID:19945496 |
| asbestos | affects expression | ISO | RGD:1349768 | 6480464 | Asbestos affects the expression of GSTM3 protein | CTD | PMID:7614465 |
| atrazine | multiple interactions | ISO | RGD:1620117 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA | CTD | PMID:22515965 |
| benzo[a]pyrene | increases expression | ISO | RGD:1349768 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM3 mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | increases expression | ISO | RGD:1620117 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM3 mRNA | CTD | PMID:21569818 PMID:21964900 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1349768 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSTM3 protein] | CTD | PMID:22138271 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1349768 | 6480464 | Benzo(a)pyrene results in decreased expression of GSTM3 protein | CTD | PMID:22138271 |
| benzo[a]pyrene | increases expression | ISO | RGD:1620117 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM3 mRNA | CTD | PMID:21569818 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1620117 | 6480464 | Diethylhexyl Phthalate results in increased expression of GSTM3 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1620117 | 6480464 | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GSTM3 mRNA] | CTD | PMID:19850644 |
| carmustine | affects metabolic processing | ISO | RGD:1349768 | 6480464 | GSTM3 protein affects the metabolism of Carmustine | CTD | PMID:15247628 |
| carmustine | decreases nitrosation | ISO | RGD:1349768 | 6480464 | GSTM3 protein results in decreased nitrosation of Carmustine | CTD | PMID:11841793 |
| carmustine | multiple interactions | ISO | RGD:1349768 | 6480464 | GSTM3 protein results in decreased nitrosation of and results in decreased activity of Carmustine | CTD | PMID:8395980 |
| chloroform | decreases expression | EXP | | 6480464 | Chloroform results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| chloroprene | increases expression | ISO | RGD:1620117 | 6480464 | Chloroprene results in increased expression of GSTM3 mRNA | CTD | PMID:23125180 |
| chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of GSTM3 mRNA | CTD | PMID:17452286 |
| chlorpyrifos | multiple interactions | ISO | RGD:1620117 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA | CTD | PMID:22515965 |
| cholic acid | increases expression | ISO | RGD:1620117 | 6480464 | Cholic Acid results in increased expression of GSTM3 mRNA | CTD | PMID:17521389 |
| cisplatin | affects response to substance | ISO | RGD:1349768 | 6480464 | GSTM3 gene polymorphism affects the susceptibility to Cisplatin | CTD | PMID:11081456 |
| cisplatin | affects response to substance | ISO | RGD:1349768 | 6480464 | GSTM3 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of GSTM3 mRNA | CTD | PMID:17602206 |
| cobalt atom | increases expression | ISO | RGD:1620117 | 6480464 | Cobalt results in increased expression of GSTM3 mRNA | CTD | PMID:22147119 |
| copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA; more ... | CTD | PMID:20302851 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA; more ... | CTD | PMID:20302851 |
| cyclosporin A | decreases expression | ISO | RGD:1620117 | 6480464 | Cyclosporine results in decreased expression of GSTM3 mRNA | CTD | PMID:19770486 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| dexamethasone | increases expression | ISO | RGD:1620117 | 6480464 | Dexamethasone results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 |
| diarsenic trioxide | increases expression | ISO | RGD:1349768 | 6480464 | arsenic trioxide results in increased expression of GSTM3 mRNA | CTD | PMID:22521957 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of GSTM3 mRNA | CTD | PMID:19440498 PMID:17452286 |
| diazinon | decreases expression | EXP | | 6480464 | Diazinon results in decreased expression of GSTM3 mRNA | CTD | PMID:17452286 PMID:19440498 |
| dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of GSTM3 mRNA | CTD | PMID:19440498 |
| diethylstilbestrol | increases expression | ISO | RGD:1349768 | 6480464 | Diethylstilbestrol results in increased expression of GSTM3 mRNA | CTD | PMID:11331657 |
| emodin | decreases expression | ISO | RGD:1349768 | 6480464 | Emodin results in decreased expression of GSTM3 mRNA | CTD | PMID:16045814 |
| endosulfan | multiple interactions | ISO | RGD:1620117 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM3 mRNA | CTD | PMID:22515965 |
| endosulfan | increases expression | ISO | RGD:1620117 | 6480464 | Endosulfan results in increased expression of GSTM3 mRNA | CTD | PMID:22515965 |
| erythromycin estolate | decreases expression | EXP | | 6480464 | Erythromycin Estolate results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of GSTM3 mRNA | CTD | PMID:16098508 |
| ethanol | increases expression | ISO | RGD:1620117 | 6480464 | Ethanol results in increased expression of GSTM3 mRNA | CTD | PMID:19167417 |
| fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA | CTD | PMID:18253720 PMID:18775883 |
| fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA | CTD | PMID:18775883 PMID:18253720 |
| fenofibrate | decreases expression | EXP | | 6480464 | Fenofibrate results in decreased expression of GSTM3 mRNA | CTD | PMID:18775883 |
| fumonisin B1 | increases expression | ISO | RGD:1620117 | 6480464 | fumonisin B1 results in increased expression of GSTM3 mRNA | CTD | PMID:16221962 |
| furan | increases expression | ISO | RGD:1620117 | 6480464 | furan results in increased expression of GSTM3 mRNA | CTD | PMID:20194422 |
| gliclazide | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] | CTD | PMID:21439372 |
| glutathione | affects metabolic processing | ISO | RGD:1349768 | 6480464 | GSTM3 protein affects the metabolism of Glutathione | CTD | PMID:9545290 |
| graphite | decreases expression | ISO | RGD:1349768 | 6480464 | Graphite results in decreased expression of GSTM3 protein | CTD | PMID:22157353 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of GSTM3 mRNA | CTD | PMID:21396975 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA | CTD | PMID:22129741 |
| iron atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of GSTM3 mRNA | CTD | PMID:20302851 |
| kojic acid | multiple interactions | ISO | RGD:1620117 | 6480464 | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA | CTD | PMID:17917374 |
| kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA; more ... | CTD | PMID:18544905 |
| L-methionine | multiple interactions | ISO | RGD:1349768 | 6480464 | [Methionine deficiency co-treated with Homocysteine] affects the expression of GSTM3 protein | CTD | PMID:17116298 |
| L-methionine | multiple interactions | ISO | RGD:1349768 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GSTM3 protein] | CTD | PMID:22138271 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of GSTM3 mRNA | CTD | PMID:18082333 |
| lithium chloride | multiple interactions | ISO | RGD:1620117 | 6480464 | [Lithium Chloride results in increased activity of CTNNB1 protein] which results in increased expression of GSTM3 mRNA | CTD | PMID:20118494 |
| microcystin-LR | increases expression | ISO | RGD:1620117 | 6480464 | cyanoginosin LR results in increased expression of GSTM3 mRNA | CTD | PMID:17654400 |
| monocrotaline | multiple interactions | ISO | RGD:1620117 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA | CTD | PMID:21224054 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of GSTM3 mRNA | CTD | PMID:14965361 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA | CTD | PMID:18775883 PMID:18253720 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA; more ... | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Copper co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA; more ... | CTD | PMID:20302851 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1620117 | 6480464 | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA | CTD | PMID:17917374 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA | CTD | PMID:18253720 PMID:18775883 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of GSTM3 mRNA | CTD | PMID:19638242 |
| naloxone | decreases expression | EXP | | 6480464 | Naloxone results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| nickel atom | affects expression | EXP | | 6480464 | Nickel affects the expression of GSTM3 mRNA | CTD | PMID:19440498 |
| nickel atom | affects expression | ISO | RGD:1349768 | 6480464 | Nickel affects the expression of GSTM3 mRNA | CTD | PMID:14575637 |
| nickel atom | multiple interactions | ISO | RGD:1349768 | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of GSTM3 mRNA] | CTD | PMID:14575637 |
| nicotinamide | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA]; more ... | CTD | PMID:21439372 |
| ozone | decreases expression | ISO | RGD:1620117 | 6480464 | Ozone results in decreased expression of GSTM3 mRNA | CTD | PMID:12763052 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| paracetamol | decreases expression | ISO | RGD:1620117 | 6480464 | Acetaminophen results in decreased expression of GSTM3 mRNA | CTD | PMID:16611625 |
| paraquat | increases expression | ISO | RGD:1620117 | 6480464 | Paraquat results in increased expression of GSTM3 mRNA | CTD | PMID:16128001 |
| paraquat | increases expression | ISO | RGD:1349768 | 6480464 | Paraquat results in increased expression of GSTM3 mRNA | CTD | PMID:20883675 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:1620117 | 6480464 | perfluorooctane sulfonic acid affects the expression of GSTM3 mRNA | CTD | PMID:19429403 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:1620117 | 6480464 | perfluorooctane sulfonic acid results in increased expression of GSTM3 mRNA | CTD | PMID:20936131 |
| perfluorooctanoic acid | affects expression | ISO | RGD:1620117 | 6480464 | perfluorooctanoic acid affects the expression of GSTM3 mRNA | CTD | PMID:18281256 PMID:19429403 |
| perfluorooctanoic acid | increases expression | ISO | RGD:1620117 | 6480464 | perfluorooctanoic acid results in increased expression of GSTM3 mRNA | CTD | PMID:20118188 PMID:18281256 |
| perfluorooctanoic acid | affects expression | ISO | RGD:1620117 | 6480464 | perfluorooctanoic acid affects the expression of GSTM3 mRNA | CTD | PMID:19429403 PMID:18281256 |
| perfluorooctanoic acid | increases expression | ISO | RGD:1620117 | 6480464 | perfluorooctanoic acid results in increased expression of GSTM3 mRNA | CTD | PMID:18281256 PMID:20118188 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1620117 | 6480464 | PPARA protein inhibits the reaction [perfluorooctanoic acid results in increased expression of GSTM3 mRNA] | CTD | PMID:18281256 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1620117 | 6480464 | [perfluorooctanoic acid co-treated with PPARA] results in decreased expression of GSTM3 mRNA | CTD | PMID:20118188 |
| phenobarbital | multiple interactions | ISO | RGD:1620117 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of GSTM3 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1620117 | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 more ... |
| phenobarbital | increases expression | ISO | RGD:1620117 | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 more ... |
| phenobarbital | increases expression | ISO | RGD:1620117 | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 more ... |
| phenobarbital | increases expression | ISO | RGD:1620117 | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA | CTD | PMID:20118494 more ... |
| phenobarbital | increases expression | ISO | RGD:1620117 | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA | CTD | PMID:20403969 more ... |
| phenobarbital | increases expression | ISO | RGD:1620117 | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA | CTD | PMID:20403969 more ... |
| phenobarbital | increases expression | ISO | RGD:1620117 | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA | CTD | PMID:20403969 more ... |
| phenobarbital | increases expression | ISO | RGD:1620117 | 6480464 | Phenobarbital results in increased expression of GSTM3 mRNA | CTD | PMID:20118494 more ... |
| phenobarbital | multiple interactions | ISO | RGD:1620117 | 6480464 | [Phenobarbital co-treated with CTNNB1 protein mutant form] results in increased expression of GSTM3 mRNA | CTD | PMID:20118494 |
| phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of GSTM3 mRNA | CTD | PMID:18158353 |
| phenytoin | multiple interactions | ISO | RGD:1620117 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA | CTD | PMID:21224054 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of GSTM3 mRNA | CTD | PMID:18544911 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of GSTM3 mRNA | CTD | PMID:18544911 PMID:22484513 |
| pirinixic acid | decreases expression | ISO | RGD:1620117 | 6480464 | pirinixic acid results in decreased expression of GSTM3 mRNA | CTD | PMID:17426115 PMID:16221962 |
| pirinixic acid | decreases expression | ISO | RGD:1620117 | 6480464 | pirinixic acid results in decreased expression of GSTM3 mRNA | CTD | PMID:16221962 PMID:17426115 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:1620117 | 6480464 | Pregnenolone Carbonitrile results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 |
| propiconazole | increases expression | ISO | RGD:1620117 | 6480464 | propiconazole results in increased expression of GSTM3 mRNA | CTD | PMID:21278054 |
| propiconazole | increases expression | ISO | RGD:1620117 | 6480464 | propiconazole results in increased expression of GSTM3 mRNA | CTD | PMID:21278054 PMID:22334560 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of GSTM3 mRNA | CTD | PMID:16643972 |
| prostaglandin E2 | affects chemical synthesis | ISO | RGD:1349768 | 6480464 | GSTM3 protein affects the chemical synthesis of Dinoprostone | CTD | PMID:10905636 |
| prostaglandin H2 | affects metabolic processing | ISO | RGD:1349768 | 6480464 | GSTM3 protein affects the metabolism of Prostaglandin H2 | CTD | PMID:10905636 |
| quercetin | decreases expression | ISO | RGD:1620117 | 6480464 | Quercetin results in decreased expression of GSTM3 mRNA | CTD | PMID:16455785 |
| quinidine | decreases expression | EXP | | 6480464 | Quinidine results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] | CTD | PMID:21439372 |
| rifampicin | multiple interactions | ISO | RGD:1620117 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM3 mRNA | CTD | PMID:21224054 |
| spironolactone | increases expression | ISO | RGD:1620117 | 6480464 | Spironolactone results in increased expression of GSTM3 mRNA | CTD | PMID:18723825 |
| streptozocin | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA]; more ... | CTD | PMID:21439372 |
| sulforaphane | multiple interactions | ISO | RGD:1620117 | 6480464 | [sulforafan co-treated with dibenzoylmethane] results in increased expression of GSTM3 mRNA | CTD | PMID:17942926 |
| sulforaphane | increases expression | ISO | RGD:1620117 | 6480464 | sulforafan results in increased expression of GSTM3 mRNA | CTD | PMID:17942926 |
| tamoxifen | affects expression | ISO | RGD:1620117 | 6480464 | Tamoxifen affects the expression of GSTM3 mRNA | CTD | PMID:17555576 |
| tetrachloromethane | multiple interactions | ISO | RGD:1620117 | 6480464 | PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of GSTM3 mRNA] | CTD | PMID:16006527 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of GSTM3 mRNA | CTD | PMID:16239168 |
| tetracycline | decreases activity | ISO | RGD:1349768 | 6480464 | Tetracycline results in decreased activity of GSTM3 protein | CTD | PMID:11807801 |
| tetracycline | decreases expression | EXP | | 6480464 | Tetracycline results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| theophylline | decreases expression | EXP | | 6480464 | Theophylline results in decreased expression of GSTM3 mRNA | CTD | PMID:17522070 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of GSTM3 mRNA | CTD | PMID:18653662 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GSTM3 mRNA] | CTD | PMID:21439372 |
| trichostatin A | multiple interactions | ISO | RGD:1349768 | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of GSTM3 mRNA] | CTD | PMID:14575637 |
| trimellitic anhydride | decreases expression | ISO | RGD:1620117 | 6480464 | trimellitic anhydride results in decreased expression of GSTM3 mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:1349768 | 6480464 | troglitazone results in decreased expression of GSTM3 mRNA | CTD | PMID:19631733 |
| troglitazone | increases expression | ISO | RGD:1349768 | 6480464 | troglitazone results in increased expression of GSTM3 mRNA | CTD | PMID:19631733 |
| tunicamycin | decreases expression | ISO | RGD:1620117 | 6480464 | Tunicamycin results in decreased expression of GSTM3 mRNA | CTD | PMID:17127020 |
| ursodeoxycholic acid | decreases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in decreased expression of GSTM3 mRNA | CTD | PMID:15885361 |
| zinc pyrithione | increases expression | ISO | RGD:1349768 | 6480464 | zinc pyrithione results in increased expression of GSTM3 mRNA | CTD | PMID:21424779 |